Skip to content

ReportsALAB10-K FY2025

SEC filings, compared

What changed in Astera Labs,'s 10-K for the fiscal year ended December 31, 2025

Compared with the 10-K for the fiscal year ended December 31, 2024. Item 1A and Item 7 analysed; every summary checked against the quoted filing text.

Registrant
Astera Labs, Inc. · ALAB
This filing
0001736297-26-000010 · filed Feb 20, 2026
Compared with
0001736297-25-000003 · filed Feb 14, 2025
Processed
Sep 20, 2026 UTC · parser-v5 · classify-v4 · select-v1

Research tool. Describes what filings say. Not investment advice. Verify independently. Read the cited paragraph before relying on it.

How a report is made

132 material changes among 209 changed paragraphs

18 shown by default across the three sections below; each section's "Show all" reaches the rest, in filing order.

Numbers from XBRL

Each figure is the one the filing itself tagged, taken from the filing that reported it. Not written by a model.

ConceptFY2025FY2024Change (our arithmetic)
Revenueus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax852,525,000USD · Jan 1, 2025 to Dec 31, 2025396,290,000USD · Jan 1, 2024 to Dec 31, 2024+456,235,000+115.1%
Net income or lossus-gaap:NetIncomeLoss219,134,000USD · Jan 1, 2025 to Dec 31, 2025(83,421,000)USD · Jan 1, 2024 to Dec 31, 2024+302,555,000+362.7%
Cash and cash equivalentsus-gaap:CashAndCashEquivalentsAtCarryingValue167,611,000USD · at Dec 31, 202579,551,000USD · at Dec 31, 2024+88,060,000+110.7%
Net cash from operating activitiesus-gaap:NetCashProvidedByUsedInOperatingActivities319,306,000USD · Jan 1, 2025 to Dec 31, 2025136,676,000USD · Jan 1, 2024 to Dec 31, 2024+182,630,000+133.6%

Values as tagged in the filing's inline XBRL, resolved by accession rather than by period matching. When a value is not tagged, we show that instead of estimating it. FY2025: 0001736297-26-000010 · FY2024: 0001736297-25-000003

What the company says for the first time

Paragraphs with no counterpart in the prior filing.

11 material additions

Item 1A · Risk Factors

5 of 8 shown · Ordered by the model, quote-checked

01AddedItem 1A › Risks Related to Our Business › Adverse changes in the political, regulatory, and economic policies of governments in connection with trade with China and Chinese customers have reduced the demand for our products and damaged our business.

Summary · quote-checked

Adds risks involving Chinese customer behavior, unreliable-supplier designation, investment and data restrictions, and indirect effects of export controls.

The new paragraph discloses additional dependencies, potential government designation, regulatory restrictions, and customer responses that substantively expand the company’s stated business risks.

Why the model ranked it here

This adds a direct China-related dependency involving customer behavior, export restrictions, input costs, and potential unreliable-supplier designation.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

Regulatory activity, such as tariffs, export controls, economic sanctions, and restrictions on investment and data transfers as well as vigorous enforcement of U.S. export controls and economic sanctions laws have in the past and may continue to materially limit our ability to make sales to our customers in China, which has in the past and may continue to harm our results of operations, reputation, and financial condition. Due to the U.S. government restricting sales to certain customers in China, sales to some of our customers may require licenses in order for us to export our products; however, there can be no assurances that requests for licenses will be approved by the U.S. government. Further, augmentation of restricted or prohibited persons lists maintained by the U.S. government could reduce our ability to sell to certain customers. Fluid tariff policies of both the U.S. and Chinese governments may reduce demand for our products and could [added] increase input costs. Moreover, concerns that U.S. companies may not be reliable suppliers as a result of these and other actions has caused, and may in the future cause, some of our customers in China to amass large inventories of our products well in advance of need or caused some of our customers to replace our products in favor of products from other suppliers. Additionally, the Chinese government adopted a law with respect to unreliable suppliers. Any designation as an unreliable supplier may have an adverse impact on our business and operations. Recent U.S. government restrictions on investments into China by U.S. persons and regarding access by Chinese persons to certain personal data relating to U.S. persons could hinder our Chinese operations. In addition, there may be indirect impacts to our business that we cannot easily quantify such as the fact that some of our other customers' systems may also be impacted by export restrictions.

Cite this change

"increase input costs. Moreover, concerns that U.S. companies may not be reliable suppliers as a result of these and other actions has caused, and may in the future cause, some of our customers in China to amass large inventories of our products well in advance of need or caused some of our customers to replace our products in favor of products from other suppliers. Additionally, the Chinese government adopted a law with respect to unreliable suppliers. Any designation as an unreliable supplier may have an adverse impact on our business and operations. Recent U.S. government restrictions on investments into China by U.S. persons and regarding access by Chinese persons to certain personal data relating to U.S. persons could hinder our Chinese operations. In addition, there may be indirect impacts to our business that we cannot easily quantify such as the fact that some of our other customers' systems may also be impacted by export restrictions."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02AddedItem 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.

Summary · quote-checked

Added disclosure of restrictions on personal data transfers, including a U.S. rule involving countries of concern and potential sanctions.

The paragraph introduces a specific regulation, jurisdictional restrictions involving China, and criminal, civil, and program-exclusion consequences, changing the disclosed regulatory risk.

Why the model ranked it here

This introduces specific restrictions on personal-data transfers with potentially severe sanctions and program-exclusion consequences.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] Regulators and legislators across the world are also increasingly scrutinizing and restricting certain personal data transfers. For example, the Department of Justice's January 8, 2025, rule on "Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons," prohibits or restricts certain data transactions involving countries of concern, including China. Actual or alleged violations of these regulations may be punishable by criminal and/or civil sanctions and may result in exclusion from participation in federal and state programs.

Cite this change

"Regulators and legislators across the world are also increasingly scrutinizing and restricting certain personal data transfers. For example, the Department of Justice's January 8, 2025, rule on "Preventing Access to U.S. Sensitive Personal Data and Government-Related Data by Countries of Concern or Covered Persons," prohibits or restricts certain data transactions involving countries of concern, including China. Actual or alleged violations of these regulations may be punishable by criminal and/or civil sanctions and may result in exclusion from participation in federal and state programs."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03AddedItem 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.

Summary · quote-checked

Adds disclosure of geopolitical cyber conflicts, cybersecurity incidents, data breaches, malware, vulnerabilities, and resulting information loss or business disruption.

The new paragraph identifies additional cyber threats, actors, affected systems, and consequences, substantively expanding disclosed business risks.

Why the model ranked it here

This expands the disclosed cybersecurity exposure to geopolitical attacks, third-party systems, data loss, business disruption, and proprietary-information compromise.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

Cyber-attacks are increasing in number and sophistication, are well-financed, in some cases supported by state actors, and are designed to not only attack, but also to evade detection, and are being facilitated or enhanced by evolving technologies, including AI. Since the techniques used to obtain unauthorized access to systems and data, or to otherwise sabotage them, change frequently and are often not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Attempts to disrupt or gain unauthorized access to our and our third-party vendors' information systems from malicious third parties or insider threats may incorporate widely varying and frequently changing tactics, which may be enhanced or facilitated by evolving technologies [added] such as AI. Geopolitical instability may also increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful cybersecurity incidents, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or the misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties.

Cite this change

"such as AI. Geopolitical instability may also increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful cybersecurity incidents, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or the misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

04AddedItem 1A › Risks Related to Our Business › The adoption, use, and commercialization of AI technology, and the continued rapid pace of developments in the AI field, are inherently uncertain. Failure by our customers to continue to adopt or invest in AI infrastructure to support AI use cases in their systems, or our ability to keep up with evolving AI infrastructure requirements, could have a material adverse effect on our business, financial condition, and results of operations.

Summary · quote-checked

Adds disclosure about increasingly complex AI regulation, compliance resources, customer commercialization delays, demand, and adoption risks.

The new paragraph introduces regulatory uncertainty, compliance obligations, potential commercialization delays, reduced customer demand, and adoption effects, substantively expanding disclosed risks.

Why the model ranked it here

This links increasingly complex AI regulation to compliance burdens, customer commercialization delays, demand, and adoption risks.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] The AI regulatory environment is increasingly complex and uncertain. For example, in the United States, states have advanced, and in some cases passed, laws focusing on AI, while the federal government has pursued a deregulatory agenda. Significant resources will be required to design, develop, test and maintain our products to help ensure that AI is implemented and deployed in accordance with applicable law and regulation and in a manner intended to comply with applicable laws and regulations and mitigate foreseeable risks. Our customers may also become subject to such existing or upcoming AI laws and regulations, which could cause a delay or impediment to the commercialization of AI technology and could lead to a decrease in demand for our customers' AI systems, and may adversely affect our business, financial condition, and results of operations. In addition, uncertainty regarding the direction of AI regulation may affect customers' adoption of AI, which could adversely affect our business.

Cite this change

"The AI regulatory environment is increasingly complex and uncertain."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

05AddedItem 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.

Summary · quote-checked

Adds disclosure that using AI may create cybersecurity, privacy, intellectual property, regulatory, operational, competitive and reputational risks.

The new paragraph identifies specific AI-related risks, including bias, harmful content, privacy-law exposure, confidentiality compromise and intellectual property infringement or ownership uncertainty.

Why the model ranked it here

This discloses that the company’s own and vendors’ AI use creates broad cybersecurity, privacy, intellectual-property, legal, operational, and reputational exposure.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] Our use of AI in our business processes may also subject us to cybersecurity, data privacy, IT, intellectual property, regulatory, legal, operational, competitive, reputational and other risks and challenges that could affect our business. Use of AI by us or our vendors could result in bias, discrimination, or harmful or inaccurate content that may be actionable under privacy, data protection, and emerging AI laws. The use of certain AI technology can also give rise to intellectual property risks, including by disclosing or otherwise compromising our confidential or proprietary intellectual property and intellectual property infringement, or by undermining our ability to assert or defend ownership rights in intellectual property created with the assistance of AI tools.

Cite this change

"Our use of AI in our business processes may also subject us to cybersecurity, data privacy, IT, intellectual property, regulatory, legal, operational, competitive, reputational and other risks and challenges that could affect our business. Use of AI by us or our vendors could result in bias, discrimination, or harmful or inaccurate content that may be actionable under privacy, data protection, and emerging AI laws. The use of certain AI technology can also give rise to intellectual property risks, including by disclosing or otherwise compromising our confidential or proprietary intellectual property and intellectual property infringement, or by undermining our ability to assert or defend ownership rights in intellectual property created with the assistance of AI tools."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

06AddedItem 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.

Summary · quote-checked

Added disclosure describing evolving and conflicting data privacy requirements, increased compliance costs, business changes, and potential penalties.

The new paragraph adds substantive legal and compliance risks, including jurisdictional conflicts, operational changes, increased costs, and significant penalties.

Why the model ranked it here

This adds evolving and potentially conflicting privacy requirements that could change operations, increase compliance complexity, and result in significant penalties.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] Data privacy laws and regulations are constantly evolving and can be subject to significant change and/or interpretive application. The lack of a unified approach to data privacy and protection laws in the U.S. and internationally could lead to complicated and potentially conflicting compliance requirements. Varying and evolving jurisdictional requirements could increase the costs and complexity of our compliance efforts and require changes to how we conduct our business. Violations of applicable data privacy laws can result in significant penalties.

Cite this change

"Data privacy laws and regulations are constantly evolving and can be subject to significant change and/or interpretive application. The lack of a unified approach to data privacy and protection laws in the U.S. and internationally could lead to complicated and potentially conflicting compliance requirements. Varying and evolving jurisdictional requirements could increase the costs and complexity of our compliance efforts and require changes to how we conduct our business. Violations of applicable data privacy laws can result in significant penalties."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

07AddedItem 1A › Risks Related to Our Business › We previously identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. Although these material weaknesses have been remediated, if we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.

Summary · quote-checked

Added a risk disclosure that ineffective financial reporting controls could adversely affect the company and common-stock trading price.

The new paragraph states a substantive consequence tied to failure to maintain effective internal control over financial reporting, adding a business and market-value risk.

Why the model ranked it here

This newly connects ineffective financial reporting controls to adverse effects on the business, financial results, and common-stock trading price.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] As a result, any failure to maintain effective internal control over financial reporting could materially and adversely affect our business, financial condition, results of operations, and the trading price of our common stock.

Cite this change

"As a result, any failure to maintain effective internal control over financial reporting could materially and adversely affect our business, financial condition, results of operations, and the trading price of our common stock."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

08AddedItem 1A › Risks Related to Our Business › Our business is subject to complex and evolving laws and regulations regarding privacy, data protection, artificial intelligence and cybersecurity, any actual or perceived failure to comply with such laws and regulations could have a material adverse effect on our business.

Summary · quote-checked

Added disclosure of privacy, data protection and cybersecurity obligations under company policies, third-party commitments and customers’ differing jurisdictional requirements.

The paragraph introduces contractual privacy obligations and potential impacts on handling personal information, adding substantive dependency and compliance disclosures.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] We are also subject to the terms of our privacy policies and obligations to third parties, including our customers, related to privacy, data protection, and cybersecurity. Our customers may also be subject to differing privacy laws, rules and legislation, which may mean that they require us to be bound by varying contractual requirements applicable to certain other jurisdictions. Adherence to such contractual requirements may impact our collection, use, processing, storage, sharing and disclosure of personal information.

Cite this change

"We are also subject to the terms of our privacy policies and obligations to third parties, including our customers, related to privacy, data protection, and cybersecurity."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show fewer in Item 1A

Item 7 · MD&A

3 of 3 shown · In filing order, too few to rank

01AddedItem 7 › Summary of Financial Highlights

Summary · quote-checked

Added disclosure that gross margin decreased due primarily to product mix from shipping more hardware modules.

The new paragraph states a changed profitability result and identifies its driver; this is substantive MD&A information, not merely a period or figure roll-forward.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] Gross margin decreased 70 bps to 75.7% for the year ended December 31, 2025 from 76.4% for the same period in 2024, primarily driven by product mix as we shipped more hardware modules.

Cite this change

"Gross margin decreased 70 bps to 75.7% for the year ended December 31, 2025 from 76.4% for the same period in 2024, primarily driven by product mix as we shipped more hardware modules."

Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02AddedItem 7 › Non-GAAP Operating Income and Non-GAAP Operating Margin

Summary · quote-checked

Added a definition of acquisition-related costs and identified the types of third-party expenses included.

The new paragraph discloses a specific non-GAAP cost category and its components, adding substantive information about expenses associated with business combinations.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] (2) Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees.

Cite this change

"(2) Acquisition-related costs include certain incremental expenses incurred to effect a business combination such as third-party costs: advisory, legal, accounting, valuation, and other professional fees."

Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03AddedItem 7 › Revenue Recognition

Summary · quote-checked

Added disclosure describing customer warrants, performance-based vesting conditions, and their treatment as consideration payable reducing recognized revenue.

The new paragraph discloses a customer-related warrant arrangement and an associated revenue-reduction obligation, revealing a new instrument and accounting exposure.

Filing text · FY2024 10-K · filed Feb 14, 2025

No corresponding language in the FY2024 10-K.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] We account for the warrants issued to a customer as consideration payable as we did not receive a distinct good or service in exchange for the warrants. The shares underlying the warrants vest upon the achievement of specified tranches of global payments by the customer and its affiliates. As it becomes probable that the performance-based vesting conditions underlying the warrants will be achieved and the related revenue is recognized, we recognize the related grant date fair value of the warrants as a reduction of revenue for each sales transaction in proportion to total expected cumulative sales volume resulting in achievement of the vesting conditions. For more information, see Note 10 - Common Stock Warrants in the Notes to the Consolidated Financial Statements set forth in Part II, Item 8 of this Annual Report on Form 10-K.

Cite this change

"We account for the warrants issued to a customer as consideration payable as we did not receive a distinct good or service in exchange for the warrants."

Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

What the company no longer says

Paragraphs of the prior filing that this filing dropped. Only last year's text can show these.

22 material removals

Item 1A · Risk Factors

2 of 8 shown · Ordered by the model, quote-checked

01RemovedItem 1A › Risks Related to Our Business › We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. If our remediation of the material weaknesses is not effective, or we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.

Summary · quote-checked

The current filing removed disclosure that the company had identified material weaknesses in internal control over financial reporting.

Removing this disclosure changes the stated condition regarding financial reporting controls and a potential material misstatement risk.

Why the model ranked it here

The removal changes the company’s stated condition regarding material weaknesses in financial reporting controls and the risk of material misstatement.

Filing text · FY2024 10-K · filed Feb 14, 2025

[removed] A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. We have identified material weaknesses in our internal control over financial reporting.

Filing text · FY2025 10-K · filed Feb 20, 2026

No corresponding language in the FY2025 10-K.

Cite this change

"A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of a company's annual or interim financial statements will not be prevented or detected on a timely basis. We have identified material weaknesses in our internal control over financial reporting."

Astera Labs,, Form 10-K for FY2024, Item 1A, accession 0001736297-25-000003, filed 14 February 2025.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629725000003/alab-20241231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02RemovedItem 1A › Risks Related to Our Business › We have identified material weaknesses in our internal control over financial reporting and may identify additional material weaknesses in the future or fail to maintain an effective system of internal control over financial reporting. If our remediation of the material weaknesses is not effective, or we fail to develop and maintain effective internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable laws and regulations could be impaired, which could harm our business and negatively impact the value of our common stock.

Summary · quote-checked

The company removed a disclosure describing inadequate risk assessment and insufficient controls over financial reporting, including segregation of duties.

The removed paragraph disclosed specific material weaknesses in internal control over financial reporting, including risks involving journal entries and account reconciliations; its removal changes the disclosed control risk.

Why the model ranked it here

The removed disclosure covered inadequate risk assessment, segregation of duties, journal entries, and account reconciliations, materially changing the reported control-risk profile.

Filing text · FY2024 10-K · filed Feb 14, 2025

[removed] We did not adequately design and maintain an effective risk assessment process at a sufficient precision level to identify risks of material misstatement in our consolidated financial statements. Specifically, the implementation of controls was not sufficient to respond to risks of material misstatement to financial reporting, including a lack of effectively designed controls over segregation of duties, particularly over the preparation and review of journal entries and account reconciliations.

Filing text · FY2025 10-K · filed Feb 20, 2026

No corresponding language in the FY2025 10-K.

Cite this change

"We did not adequately design and maintain an effective risk assessment process at a sufficient precision level to identify risks of material misstatement in our consolidated financial statements. Specifically, the implementation of controls was not sufficient to respond to risks of material misstatement to financial reporting, including a lack of effectively designed controls over segregation of duties, particularly over the preparation and review of journal entries and account reconciliations."

Astera Labs,, Form 10-K for FY2024, Item 1A, accession 0001736297-25-000003, filed 14 February 2025.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629725000003/alab-20241231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 8 in Item 1A (6 more, in filing order)

Item 7 · MD&A

3 of 14 shown · Ordered by the model, quote-checked

01RemovedItem 7 › Revenue Recognition

Summary · quote-checked

The revenue recognition disclosure describing receivables, deferred revenue, and performance obligations extending beyond one year was removed.

Removing the paragraph eliminates substantive disclosure about deferred revenue obligations and contracts with performance obligations extending beyond one year, not merely presentation or calculation mechanics.

Why the model ranked it here

This removes disclosure of deferred revenue and performance obligations extending beyond one year, obscuring the company’s stated contractual obligations.

Filing text · FY2024 10-K · filed Feb 14, 2025

[removed] Accounts receivable are recorded when the customer has been billed or the right to consideration is unconditional. We record deferred revenue when we have received consideration, or an amount of consideration is due from the customer, and we have a future obligation to transfer products or services. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year.

Filing text · FY2025 10-K · filed Feb 20, 2026

No corresponding language in the FY2025 10-K.

Cite this change

"Accounts receivable are recorded when the customer has been billed or the right to consideration is unconditional. We record deferred revenue when we have received consideration, or an amount of consideration is due from the customer, and we have a future obligation to transfer products or services. From time to time, we have contracts with initial terms that include performance obligations that extend beyond one year."

Astera Labs,, Form 10-K for FY2024, Item 7, accession 0001736297-25-000003, filed 14 February 2025.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629725000003/alab-20241231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02RemovedItem 7 › Revenue Recognition

Summary · quote-checked

The revenue recognition disclosure about distributor resale pricing and subsequent credit memos was removed.

The removed paragraph described distributor pricing practices and the company’s obligation to issue credit memos, changing disclosed revenue-recognition mechanics.

Why the model ranked it here

This removes the explanation of distributor resale pricing and credit memos, which is important for understanding the company’s revenue-recognition mechanics.

Filing text · FY2024 10-K · filed Feb 14, 2025

[removed] We sell the majority of our products to distributors at a fixed list price. Distributors are authorized to resell our products to customers at a range of individually negotiated price points based on a variety of factors, including customer, product, quantity, geography, and competitive differentiation. The majority of our distributors' resales are priced at a discount from list price (the original purchase price). After the resale transaction is completed, we issue credit memos to the distributor for the price adjustments.

Filing text · FY2025 10-K · filed Feb 20, 2026

No corresponding language in the FY2025 10-K.

Cite this change

"We sell the majority of our products to distributors at a fixed list price. Distributors are authorized to resell our products to customers at a range of individually negotiated price points based on a variety of factors, including customer, product, quantity, geography, and competitive differentiation. The majority of our distributors' resales are priced at a discount from list price (the original purchase price). After the resale transaction is completed, we issue credit memos to the distributor for the price adjustments."

Astera Labs,, Form 10-K for FY2024, Item 7, accession 0001736297-25-000003, filed 14 February 2025.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629725000003/alab-20241231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03RemovedItem 7 › Initial Public Offering

Summary · quote-checked

The current MD&A omits disclosure of cumulative stock-based compensation expense and the related tax withholding obligation paid after the IPO.

The removed paragraph disclosed specific recognized compensation expense, an IPO-triggered vesting event, and a related tax withholding payment, changing the stated obligations and transaction disclosure.

Why the model ranked it here

This removes disclosure of IPO-triggered stock-based compensation recognition and the related tax withholding obligation, eliminating a significant stated compensation-related cash requirement.

Filing text · FY2024 10-K · filed Feb 14, 2025

[removed] We recognized $88.9 million of cumulative stock-based compensation expense associated with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO. Based on our IPO price of $36.00 per share, our tax withholding obligation in connection with the vesting of these RSUs was $20.1 million, which we paid in the first quarter of 2024.

Filing text · FY2025 10-K · filed Feb 20, 2026

No corresponding language in the FY2025 10-K.

Cite this change

"We recognized $88.9 million of cumulative stock-based compensation expense associated with the time-based vesting and settlement of RSUs that had previously met the time-based vesting condition and for which the liquidity event vesting condition was satisfied in connection with our IPO."

Astera Labs,, Form 10-K for FY2024, Item 7, accession 0001736297-25-000003, filed 14 February 2025.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629725000003/alab-20241231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 14 in Item 7 (11 more, in filing order)

What the company says differently

Paragraphs that changed between the two filings, shown as a word diff.

99 material changes

Item 1A · Risk Factors

3 of 61 shown · Ordered by the model, quote-checked

01ChangedItem 1A › Risks Related to Our Business › We have a limited history of generating net income, and if we are unable to achieve adequate revenue growth while our expenses increase, we may not maintain profitability in the future.

Summary · quote-checked

The disclosure changes from a history of net losses to limited net income history and adds 2025 net income and retained earnings information.

Reporting net income and retained earnings materially changes the stated profitability and accumulated-deficit position, beyond a routine annual roll-forward.

Why the model ranked it here

The company now describes a limited history of net income rather than a history of net losses, materially changing the reader’s understanding of its profitability and retained-earnings position.

Filing text · FY2024 10-K · filed Feb 14, 2025

We have a history of generating net [removed] losses. We incurred net losses of $83.4 million and $26.3 million for the years ended December 31, 2024 and 2023, respectively. As of December 31, 2024 and 2023, we had [removed] an accumulated deficit of $208.8 million and $125.4 million, respectively. [removed] These losses and [removed] our accumulated deficit are a result of the substantial investments we have made to grow our business. We expect our costs will increase over time and our losses may continue if such increases in costs are not more than fully offset by increases in our revenue. We expect to continue to invest significant additional funds in expanding our business and research and development activities as we continue to develop new products. We have experienced and expect to continue to incur additional general and administrative expenses as a result of our growth and increased costs to support our operations as a public company. Historically, our costs have increased over the years due to these factors, and we expect to continue to incur increasing costs to support our anticipated future growth.

Filing text · FY2025 10-K · filed Feb 20, 2026

We have a [added] limited history of generating net [added] income. We recorded net income of $219.1 million and incurred net losses of $83.4 million and $26.3 million for the years ended December 31, [added] 2025, 2024 and 2023, respectively. As of December 31, [added] 2025, 2024 and 2023, we had [added] retained earnings of $10.3 million and accumulated deficits of $208.8 million and $125.4 million, respectively. [added] Our historical losses and [added] accumulated deficits were a result of the substantial investments we have made to grow our business. We expect our costs will [added] continue to increase over time and our losses may continue if such increases in costs are not more than fully offset by increases in our revenue. We expect to continue to invest significant additional funds in expanding our business and research and development activities as we continue to develop new products. We have experienced and expect to continue to incur additional general and administrative expenses as a result of our growth and increased costs to support our operations as a public company. Historically, our costs have increased over the years due to these factors, and we expect to continue to incur increasing costs to support our anticipated future growth.

Cite this change

"We have a limited history of generating net income. We recorded net income of $219.1 million and incurred net losses of $83.4 million and $26.3 million for the years ended December 31, 2025, 2024 and 2023, respectively."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02ChangedItem 1A › Risks Related to Our Business › A substantial portion of our revenue is driven by a limited number of our end customers, and the loss of, or a significant reduction in, demand from one or a few of our top end customers would adversely affect our operations and financial condition.

Summary · quote-checked

Customer concentration increased substantially, with one end customer exceeding 70% of revenue and the top three accounting for approximately 86%.

The figures change the stated customer-concentration exposure, from no customer above 40% and top three at approximately 80% to one above 70% and top three at approximately 86%.

Why the model ranked it here

Customer concentration has increased substantially, making dependence on a single end customer a far more significant risk to revenue and operations.

Filing text · FY2024 10-K · filed Feb 14, 2025

A substantial portion of our revenue is driven by a limited number of end customers. In [removed] 2024, no end customer represented more than [removed] 40% of our revenue; the top three end customers represented an aggregate of approximately [removed] 80% of our revenue. Our distributors and end customers' manufacturing partners provide us with information in their purchase orders about which end customer will receive the products purchased. This data allows us to estimate the portion of our revenue that is due to specific end customer demand. We anticipate that we will continue to be dependent on a limited number of end customers for a significant portion of our revenue in the future, and in some cases, the portion of our revenue attributable to certain end customers may increase in the future. However, we may not be able to maintain or increase sales to certain of our top end customers for a variety of reasons, including the following:

Filing text · FY2025 10-K · filed Feb 20, 2026

A substantial portion of our revenue is driven by a limited number of end customers. In [added] 2025, one end customer represented more than [added] 70% of our revenue; the top three end customers represented an aggregate of approximately [added] 86% of our revenue. Our distributors and end customers' manufacturing partners provide us with information in their purchase orders about which end customer will receive the products purchased. This data allows us to estimate the portion of our revenue that is due to specific end customer demand. We anticipate that we will continue to be dependent on a limited number of end customers for a significant portion of our revenue in the future, and in some cases, the portion of our revenue attributable to certain end customers may increase in the future. However, we may not be able to maintain or increase sales to certain of our top end customers for a variety of reasons, including the following:

Cite this change

"In 2025, one end customer represented more than 70% of our revenue; the top three end customers represented an aggregate of approximately 86% of our revenue."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

03ChangedItem 1A › Risks Related to Our Business › Cybersecurity risks, including cyber-attacks, cybersecurity incidents, data breaches, and system vulnerabilities could adversely affect our business and disrupt our operations.

Summary · quote-checked

The disclosure changes from hypothetical cybersecurity events to stating that the company and vendors have experienced cyber-attacks or unauthorized intrusions.

The modality changes from potential events to reported experience, materially changing the asserted cybersecurity exposure; related notification, disclosure, fine, and sanction language was also removed.

Why the model ranked it here

The disclosure changes cybersecurity from a hypothetical threat to an event the company and its vendors have actually experienced.

Filing text · FY2024 10-K · filed Feb 14, 2025

Cyber-attacks are increasing in number and sophistication, are well-financed, in some cases supported by state actors, and are designed to not only attack, but also to evade detection. Since the techniques used to obtain unauthorized access to systems and data, or to otherwise sabotage them, change frequently and are often not recognized until launched against a target, we may be unable to anticipate these techniques or to implement adequate preventative measures. Geopolitical instability may increase the likelihood that we will experience direct or collateral consequences from cyber conflicts between nation-states or other politically motivated actors targeting critical technology infrastructure. Accidental or willful security breaches, data breaches, or other unauthorized access to our information systems or the systems of our third-party service providers, or the existence of computer viruses, malware (such as ransomware), or vulnerabilities in our or their data or software could expose us to a risk of information loss, business disruption, or misappropriation of proprietary and confidential information, including information relating to our products or customers or the personal information of our employees or third parties. Despite our internal controls and investment in security measures, we have in the past, and may again in the future, be subject to cyber-attacks or unauthorized network intrusions. [removed] These events, should they occur, could disrupt our business and result in, among other things, unfavorable publicity, damage to our reputation, loss of our trade secrets and other competitive information, litigation by affected [removed] parties and possible financial obligations for liabilities and damages related to the theft or misuse of [removed] such information, significant remediation costs, disruption of key business operations, and significant diversion of our [removed] resources, legal notifications and disclosures, as well as fines and other sanctions resulting from any related breaches of data privacy laws and regulations (such as the CCPA), any of which could have a material adverse effect on our business, profitability, and financial condition. In addition, despite our internal controls and processes, malicious code, and cybersecurity vulnerabilities in our products and services may expose our customers to cyberattacks and other security risks, which may result in claims, regulatory action, or reputational damage. While we may be entitled to damages if an adverse event arises from our third-party service providers' failure to perform under their agreements with us, any award may be insufficient to cover the actual costs incurred by us and, as a result of a service provider's failure to perform, we may be unable to collect any damages.

Filing text · FY2025 10-K · filed Feb 20, 2026

[added] Despite our internal controls and investment in security measures, we, and our third-party vendors, have been subject to cyber-attacks or unauthorized network intrusions. Should a cybersecurity incident or data breach occur, it could disrupt our business and result in, among other things, unfavorable publicity, damage to our reputation, loss of our trade secrets and other competitive information, litigation by affected [added] parties, possible financial obligations for liabilities and damages related to the theft or misuse of [added] any personal or confidential information, significant remediation costs, disruption of key business operations, and significant diversion of our [added] resources. Any of such events could have a material adverse effect on our business, profitability, and financial condition. In addition, despite our internal controls and processes, malicious code, and cybersecurity vulnerabilities in our products and services may expose our customers to cyberattacks and other security risks, which may result in claims, regulatory action, or reputational damage. While we may be entitled to damages if an adverse event arises from our third-party service providers' failure to perform under their agreements with us, any award may be insufficient to cover the actual costs incurred by us and, as a result of a service provider's failure to perform, we may be unable to collect any damages.

Cite this change

"Despite our internal controls and investment in security measures, we, and our third-party vendors, have been subject to cyber-attacks or unauthorized network intrusions."

Astera Labs,, Form 10-K for FY2025, Item 1A, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 61 in Item 1A (58 more, in filing order)

Item 7 · MD&A

2 of 38 shown · Ordered by the model, quote-checked

01ChangedItem 7 › Summary of Financial Highlights

Summary · quote-checked

The disclosure changed from explaining cash used in operating activities to reporting net income and its year-over-year increase.

The MD&A metric, direction, and drivers changed substantively: a cash-flow use with operating explanations was replaced by positive net income and its increase.

Why the model ranked it here

The company reports positive net income after previously reporting a loss, materially changing the earnings picture.

Filing text · FY2024 10-K · filed Feb 14, 2025

Net [removed] cash used in operating activities for the year ended December 31, [removed] 2023 of $12.7 million resulted primarily from a net loss of [removed] $26.3 million and cash used in operating assets and liabilities of $9.7 million offset by non-cash charges of $23.2 million primarily consisting of stock-based compensation of $10.7 million, an inventory write down of $10.3 million and depreciation of $1.8 million. Cash used in operating assets and liabilities during the period was primarily from a $5.6 million increase in inventory primarily due to build up for anticipated demand, a $4.3 million decrease in accounts payable primarily due to timing of payments, and a $1.3 million decrease in operating lease liability due to the maturing of the lease, and $0.7 million decrease in prepaid expenses and other assets due to timing. These cash flow uses were partially offset by a $2.4 million decrease in accounts receivable due to timing of customer payments.

Filing text · FY2025 10-K · filed Feb 20, 2026

Net [added] income was $219.1 million for the year ended December 31, [added] 2025 compared to a net loss of [added] $83.4 million for the year ended December 31, 2024, representing a $302.6 million year-over-year increase.

Cite this change

"Net income was $219.1 million for the year ended December 31, 2025 compared to a net loss of $83.4 million for the year ended December 31, 2024, representing a $302.6 million year-over-year increase."

Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

02ChangedItem 7 › Change in Cash Flows from Operating Activities

Summary · quote-checked

Operating cash flow discussion changed from 2024 results and drivers to 2025 results, including a substantial increase and different underlying drivers.

The reported cash-flow direction, amounts, and explanations changed. The current paragraph identifies increased net income and unfavorable working-capital changes, replacing the prior period’s loss and specific operating-asset movements.

Why the model ranked it here

Operating cash generation increased substantially, with the drivers shifting from IPO-related non-cash items and losses to net income and working-capital changes.

Filing text · FY2024 10-K · filed Feb 14, 2025

Net cash provided by operating activities for the year ended December 31, [removed] 2024 of $136.7 million resulted primarily from non-cash charges of $233.4 million primarily related to $234.6 million in stock-based compensation expense partially offset by a net loss of $83.4 million and cash used by operating assets and liabilities of $13.3 million. Cash used in operating assets and [removed] liabilities during the period was primarily [removed] from an increase of $30.5 million in accounts receivable due to higher product sales and timing of customer payments, $19.3 million increase in inventory for anticipated future demand, a $13.0 million increase in prepaid expenses and other assets primarily related to accrued interest receivable on our short-term investments, and $2.4 million decrease in operating lease liability. The net cash flow used in operating assets and liabilities were partially offset by $31.0 million increase in [removed] accrued expenses and other [removed] liabilities primarily due to [removed] accrued customer deposits and timing of payments, a $20.9 million increase in accounts [removed] payable primarily due to timing of [removed] payments, as well as increase in purchases.

Filing text · FY2025 10-K · filed Feb 20, 2026

Net cash provided by operating activities for the year ended December 31, [added] 2025 was $319.3 million, compared to $136.7 million for the comparable period in 2024. The $182.6 million increase in net cash provided by operating activities was a result of a $302.6 million increase in net income, partially offset by both lower non-cash charges of $67.3 million and an unfavorable change of $52.7 million from changes in operating assets and [added] liabilities. The lower non-cash charges of $67.3 million was primarily [added] due to a $74.6 million decrease in non-cash stock-based compensation expense, partially offset by increased warrants contra revenue of $4.1 million and increased depreciation and amortization expense of $3.7 million. The unfavorable change of $52.7 million from changes in operating assets and liabilities was primarily attributable to (i) a $21.9 million unfavorable change in accounts payables and accrued other liabilities primarily due to the timing of payments, (ii) a $20.7 million increase in [added] the changes of the prepaid expenses and other [added] assets primarily due to [added] prepayment for a research and development vendor and a higher income tax receivable from excess tax benefits related to equity compensation, and (iii) a $13.9 million unfavorable change in accounts [added] receivable due to [added] higher product sales and the timing of [added] customer payments. These unfavorable changes were partially offset by a reduced inventory balance of $6.3 million.

Cite this change

"Net cash provided by operating activities for the year ended December 31, 2025 was $319.3 million, compared to $136.7 million for the comparable period in 2024. The $182.6 million increase in net cash provided by operating activities was a result of a $302.6 million increase in net income, partially offset by both lower non-cash charges of $67.3 million and an unfavorable change of $52.7 million from changes in operating assets and liabilities."

Astera Labs,, Form 10-K for FY2025, Item 7, accession 0001736297-26-000010, filed 20 February 2026.

Filing: https://www.sec.gov/Archives/edgar/data/1736297/000173629726000010/alab-20251231.htm

Comparison: https://yearover.com/reports/alab/0001736297-26-000010?ref=quote

Summaries are written by a model and checked against the quoted text. The quotes are the record.

Show all 38 in Item 7 (36 more, in filing order)

Get this when ALAB files next

At most one email a day, and only when a company we cover files. Over the last twelve months that averaged about 5 days a month, unevenly: 12 in the busiest month and 1 in the quietest. You confirm by email first; nothing is sent until you do.

We store your email address. Nothing else. Privacy.